EFFECTIVENESS OF NAVAKARSHIKA KWATHAM IN HYPERURICEMIA

EFFECT OF NAVAKARSHIKA KWATHAM IN HYPERURICEMIA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/06/034177

Enrollment

Registered

2021-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

Intervention1: NAVAKARSHIKA KWATHAM: The study drug NAVAKARSHIKA KWATHAM mentioned in chakradutta vatharaktha chikitsa having 9 ingredients such as triphala,nimba,manjishta,vacha,katurohini,gudoochi,d

Eligibility

Inclusion criteria

Inclusion criteria: Male and female of age group 30-60 years having serum uric acid levels above 6.8 mg/dl for men and 5.7 mg/dl for women

Exclusion criteria

Exclusion criteria: Pregnancy and lactation , Known cases of medications for any type of neoplastic diseases , Patients on prolonged medication with corticosteroids or antidepressants and diuretics

Design outcomes

Primary

Measure	Time frame
Estimation of changes in serum uric acidTimepoint: 30 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactSUJINA V S

GOVT AYURVEDA COLLEGE TRIVANDRUM

ambikachitharanjan@gmail.com9847457084

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026